The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D001464:Barium; D001794:Blood Pressure; D002264:Carboxylic Acids / Q000627:therapeutic use; D003331:Coronary Vessels / Q000502:physiology; D004071:Digitalis Glycosides; D004285:Dogs; D004562:Electrocardiography; D006352:Heart Ventricles; D007664:Ketosteroids / Q000627:therapeutic use; D008026:Ligation; D009638:Norepinephrine; D009928:Organ Specificity; D010042:Ouabain; D011245:Pregnadienes / Q000627:therapeutic use*; D013324:Strontium; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D002264:Carboxylic Acids; D004071:Digitalis Glycosides; D007664:Ketosteroids; D011245:Pregnadienes; D001464:Barium; D010042:Ouabain; D009638:Norepinephrine; D013324:Strontium